These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25070798)

  • 1. From genomics to diagnostics of esophageal adenocarcinoma.
    Vaughan TL
    Nat Genet; 2014 Aug; 46(8):806-7. PubMed ID: 25070798
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics. Driver genes are mutated early in the course of oesophageal adenocarcinoma.
    Wood NJ
    Nat Rev Gastroenterol Hepatol; 2014 Aug; 11(8):453. PubMed ID: 25023036
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics: Driver genes are mutated early in the course of oesophageal adenocarcinoma.
    Wood NJ
    Nat Rev Clin Oncol; 2014 Aug; 11(8):439. PubMed ID: 25027592
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies.
    Zhou Z; Bandla S; Ye J; Xia Y; Que J; Luketich JD; Pennathur A; Peters JH; Tan D; Godfrey TE
    BMC Gastroenterol; 2014 Apr; 14():78. PubMed ID: 24742107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutation of p53 gene in esophageal precancerous cells].
    Kou Y; Zhang J; Chen G; Wu Z; Yang J; Jiang G; Zhao Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):306-9. PubMed ID: 12947722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying big GWAS data to clarify the role of obesity in Barrett's esophagus and esophageal adenocarcinoma.
    Abrams JA; Chak A
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269700
    [No Abstract]   [Full Text] [Related]  

  • 7. Barrett's esophagus: evolutionary insights from genomics.
    Jankowski JA; Satsangi J
    Gastroenterology; 2013 Apr; 144(4):667-9. PubMed ID: 23439235
    [No Abstract]   [Full Text] [Related]  

  • 8. p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China.
    Wang LD; Zhou Q; Hong JY; Qiu SL; Yang CS
    Cancer; 1996 Apr; 77(7):1244-9. PubMed ID: 8608498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of p53 gene mutation in esophageal exfoliative cells].
    Kou YL; Zhang JR; Zhou Q; Zhao YF; Chen GD
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):349-52. PubMed ID: 15312345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
    Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
    Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
    [No Abstract]   [Full Text] [Related]  

  • 11. The pathogenesis of Barrett's esophagus.
    Fitzgerald RC; Farthing MJ
    Gastrointest Endosc Clin N Am; 2003 Apr; 13(2):233-55. PubMed ID: 12916657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel genetic marker for dilated end stage oesophagus and oesophageal adenocarcinoma risk?
    Lenglinger J; Riegler M
    Gut; 2010 Feb; 59(2):275; author reply 275. PubMed ID: 20176646
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
    Kan T; Meltzer SJ
    Curr Opin Pharmacol; 2009 Dec; 9(6):727-32. PubMed ID: 19773200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
    Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
    Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
    Bennett WP; Hollstein MC; Metcalf RA; Welsh JA; He A; Zhu SM; Kusters I; Resau JH; Trump BF; Lane DP
    Cancer Res; 1992 Nov; 52(21):6092-7. PubMed ID: 1394236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma.
    Lian Y; Niu X; Cai H; Yang X; Ma H; Ma S; Zhang Y; Chen Y
    Tumour Biol; 2017 Jul; 39(7):1010428317715804. PubMed ID: 28671049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Barrett's adenocarcinoma.
    Melzer E; Shtoyerman R; Appelman Z; Kashtan H
    Am J Gastroenterol; 2006 Mar; 101(3):677. PubMed ID: 16542304
    [No Abstract]   [Full Text] [Related]  

  • 18. Genomic studies track early hints of cancer.
    Ledford H
    Nature; 2017 Oct; 551(7678):18. PubMed ID: 29094716
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy.
    Lin X; Finkelstein SD; Zhu B; Ujevich BJ; Silverman JF
    Cancer; 2009 Feb; 117(1):57-66. PubMed ID: 19347831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of chromosomal aberrations in epithelium adjacent to esophageal cancer (EC) and in esophageal cancer cell line EC8501.
    Su YA; Wang XQ; Hu N; Pei XF; Wang ZH; Zhou CN; Wang J; Wu M
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):84-9. PubMed ID: 3194379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.